Abstract
Cryptococcosis is an often fatal opportunistic fungal infection. Despite efforts to elucidate the role of immunity in host defense against the disease, much remains to be learned. The purpose of this brief review is to provide the reader with an overview of the history of research concerned with host immunity in cryptococcosis. Both humoral and cell-mediated studies are included. An effort has been made to present the reader with a comprehensive list of references in the hope of encouraging additional reading and research in this important area.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abrahams, I., 1966. Further studies on acquired resistance to murine cryptococcosis: Enhancing effect of Bordetella pertussis. J. Immunol. 96: 525–529.
Abrahams, I. & Gilleran, T. G., 1960. Studies on actively acquired resistance to experimental cryptococcosis in mice. J. Immunol. 85: 629–635.
Abrahams, I., Stoffer, H. R. & Payette, K. M., 1970. Cellular immunity in experimental murine cryptococcosis. Fed. Proc. 29: A503.
Atkinson, A. J., Jr. & Bennett, J. E., 1968. Experience with a new skin test antigen prepared from Cryptococcus neoformans. Am. Rev. Respir. Dis. 97: 637–643.
Baum, G. L. & Artis, D., 1963. Characterization of the growth inhibition factor for Cryptococcus neoformans (GIFc) in human serum. Amer. J. Med. Sci. 246: 53–57.
Beemer, A. M., Davidson, W., Kuttin, E. C., Zydon, Y. & Pinto, M., 1976. Vaccine and mycostatin in treatment of cryptococcosis of the respiratory tract. Sabouraudia 14: 171–179.
Bennett, J. E. & Hasenclever, H. F., 1965. Cryptococcus neoformans polysaccharide: studies of serologic properties and role in infection. J. Immunol. 94: 916–920.
Bennett, J. E., Hasenclever, H. F. & Baum, G. L., 1965. Evaluation of a skin test for cryptococcosis. Am. Rev. Respir. Dis. 91: 616.
Bergman, F. & Stormby, K., 1965. A study of white blood cell and antibody response in mice infected subcutaneously with Cryptococcus neoformans. Sabouraudia 4: 106–111.
Bloomfield, N., Gordon, M. A. & Elmendorf, Jr., D. F., 1963. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc. Soc. Exp. Biol. Med. 114: 64–67.
Bulmer, G. S. & Sans, M. D., 1967. Cryptococcus neoformans. II. Phagocytosis by human leukocytes. J. Bacteriol. 94: 1480–1483.
Bulmer, G. S. & Sans, M. D., 1968. Cryptococcus neoformans. III. Inhibition of phagocytosis. J. Bacteriol. 95: 5–8.
Bulmer, G. S., Sans, M. D. & Gunn, C. M., 1967. Cryptococcus neoformans. I. Nonencapsulated mutants. J. Bacteriol. 94: 1475–1479.
Bulmer, G. S. & Tacker, J. R., 1975. Phagocytosis of Cryptococcus neoformans by alveolar macrophages. Infect. Immun. 11: 73–79.
Cauley, L. K. & Murphy, J. W., 1979. Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun. 23: 644–651.
Diamond, R. D., 1977. Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis. Infect. Immun. 17: 187–194.
Diamond, R. D. & Bennett, J. E., 1973. Disseminated cryptococcosis in man: Decreased lymphocyte tansformation in response to Cryptococcus neoformans. J. Infect. Dis. 127: 694–697.
Diamond, R. D. & Bennett, J. E., 1973. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect. Immun. 7: 231–236.
Diamond, R. D., May, J. E., Kane, M. A., Frank, M. M. & Bennett, J. E., 1973. The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proc. Soc. Exp. Biol. Med. 144: 312–315.
Diamond, R. D., May, J. E., Kane, M. A., Frank, M. M. & Bennett, J. E., 1974. The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J. Immunol. 112: 2260–2270.
Diamond, R. D., Root, R. K. & Bennett, J. E., 1972. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J. Infect. Dis. 125: 367–376.
Dykstra, M. A. & Friedman, L., 1978. Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis. Infect. Immun. 20: 446–455.
Farhi, F., Bulmer, G. S. & Tacker, J. R., 1970. Cryptococcus neoformans. IV. The not-so-encapsulated yeast. Infect. Immun. 1: 526–531.
Farmer, S. G. & Komorowski, R. A., 1973. Histologic response to capsule-deficient Cryptococcus neoformans. Arch. Pathol. 96: 383–387.
Fisher, B. D. & Armstrong, D., 1977. Cryptococcal interstitial pneumonia. Value of antigen determination. N. Engl. J. Med. 297: 1440–1441.
Fromtling, R. A., 1979. Ecologic, immunologic and pathologic analysis of cryptococcosis. Doctor of Philosophy dissertation. University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 71 p.
Fromtling, R. A., Blackstock, R. & Bulmer, G. S., 1980. Immunization and passive transfer of immunity in murine cryptococcosis, p. 122–125. In: E. S. Kuttin and G. L. Baum (ed.) Human and animal mycology. Proc. VII Congress of ISHAM, International Congress Series No. 480, Excerpta Medica, New York.
Fromtling, R. A., Blackstock, R., Hall, N. K. & Bulmer, G. S., 1979. Immunization of mice with anavirulent pseudohyphal form of Cryptococcus neoformans. Mycopathologia 68: 179–181.
Fromtling, R. A., Blackstock, R., Hall, N. K. & Bulmer, G. S., 1979. Kinetics of lymphocyte transformation in mice immunized with viable avirulent forms of Cryptococcus neoformans. Infect. Immun. 24: 449–453.
Fromtling, R. A., Shadomy, H. J. & Jacobson, E. S., 1981. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia (in press).
Gadebusch, H. H., 1958. Active immunization against Cryptococcus neoformans. J. Infect. Dis. 102: 219–226.
Gadebusch, H. H., 1958. Passive immunization against Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 98: 611–614.
Gadebusch, H. H. & Johnson, A. G., 1966. Natural host resistance to infection with Cryptococcus neoformans. V. The influence of cationic tissue proteins upon phagocytosis and on circulating antibody synthesis. J. Infect. Dis. 116: 566–572.
Gentry, L. O. & Remington, J. S., 1971. Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J. Infect. Dis. 123: 22–31.
Gordon, M. A. & Veddar, D. K., 1966. Serologic tests in diagnosis and prognosis of cryptococcosis. J. Am. Med. Assoc. 197: 961–967.
Goren, M. B., 1967. Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide. J. Immunol. 98: 914–922.
Goren, M. B. & Middlebrook, G. M., 1967. Protein conjugates of polysaccharide from Cryptococcus neoformans. J. Immunol. 98: 901–913.
Goren, M. B. & Warren, J., 1968. Immunofluorescence studies of reactions at the cryptococcal capsule. J. Infect. Dis. 118: 215–229.
Graybill, J. R. & Alford, R. H., 1974. Cell-mediated immunity in cryptococcosis. Cell. Immunol. 14: 12–21.
Graybill, J. R. & Drutz, D. J., 1978. Host defense in cryptococcosis. II. Cryptococcosis in the nude mouse. Cell. Immunol. 40: 263–274.
Graybill, J. R. & Mitchell, L., 1979. Host defense in cryptococcosis. III. In vivo alteration of immunity. Mycopathologia 69: 171–178.
Graybill, J. R. & Taylor, R., 1976. Immunization against cryptococcosis. Clin. Res. 24: 49A.
Graybill, J. R. & Taylor, R. L., 1978. Host defense in cryptococcosis. I. An in vivo model for evaluating immune response. Int. Arch. Allergy Appl. Immunol. 57: 101–113.
Gutierrez, F., Fu, Y. S. & Lurie, H. I., 1975. Cryptococcosis histologically resembling histoplasmosis. Arch. Pathol. 99: 347–352.
Hay, R. J. & Reiss, E., 1978. Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans. Infect. Immun. 22: 72–79.
Hoff, C. L., 1942. Immunity studies of Cryptococcus hominis (Torula histolytica) in mice. J. Lab. Clin. Med. 27: 751–754.
Igel, H. J. & Bolande, R. P., 1966. Humoral defense mechanisms in cryptococcosis: substances in normal human serum, saliva, and cerebrospinal fluid affecting the growth of Cryptococcus neoformans. J. Infect. Dis. 116: 75–88.
Kalina, M., Kletter, Y. & Aronson, M., 1974. The interaction of phagocytes and the large sized parasite Cryptococcus neoformans: Cytochemical and ultrastructural study. Cell Tiss. Res. 152: 165–174.
Kanda, M., Moriyama, M., Ikeda, M., Kojima, S., Tokunaga, M. & Watanabe, G., 1974. A statistical survey of deep mycoses in Japan, with particular reference to autopsy cases of cryptococcosis. Acta. Pathol. Jap. 24: 595–609.
Karaoui, R. M., Hall, N. K. & Larsh, H. W., 1977. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route. Part I: pathogenesis and acquired immunity of Cryptococcus neoformans. Mykosen 20: 380–388.
Karaoui, R. M., Hall, N. K. & Larsh, H. W., 1977. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route. Part II: phagocytosis and intracellular fate of Cryptococcus neoformans. Mykosen 20: 409–422.
Kaufman, L. & Blumer, S., 1977. Cryptococcosis: the awakening giant, p. 176–182. In: Pan American Health Organization, Proc. of the IV International Conference on the Mycoses. PAHO Scientific Publication No. 356.
Kimball, H. R., Hasencleaver, H. F. & Wolff, S. M., 1967. Detection of circulating antibody in human cryptococcosis by means of a bentonite flocculation technique. Am. Rev. Respir.Dis. 95: 631–637.
Kligman, A. M., 1947. Studies of the capsular substance of Torula histolytica and the immunologic properties of Torula cells. J. Immunol. 57: 395–401.
Kozel, T. R. & Cazin, Jr., J., 1971. Nonencapsulated variant of Cryptococcus neoformans. I. Virulence studies of soluble polysaccharide. Infect. Immun. 3: 287–294.
Kozel, T. R. & Cazin, Jr., J., 1972. Immune response to Cryptococcus neoformans soluble polysaccharide. I. Serological assay for antigen and antibody. Infect. Immun. 5: 35–41.
Kozel, T. R. & Cazin, Jr., J., 1974. Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans. Mycopath. Mycol. Appl. 54: 21–30.
Kozel, T. R. & Follette, J. L., 1981. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody. Infect. Immun. 31: 978–984.
Kozel, T. R., Gulley, W. F. & Cazin, Jr., J., 1977. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect. Immun. 18: 701–707.
Kozel, T. R. & McGaw, T. G., 1979. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages. Infect. Immun. 25: 255–261.
Kozel, T. R. & Mastroianni, R. P., 1976. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect. Immun. 14: 62–67.
Laxalt, K. A. & Kozel, T. R., 1979. Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 26: 435–440.
Lim, T. S. & Murphy, J. W., 1980. Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans — sensitized mice. Infect. Immun. 30: 5–11.
Louria, D. B., 1960. Specific and non-specific immunity in experimental cryptococcosis in mice. J. Exp. Med. 111: 643–665.
Louria, D. B. & Kaminski, T., 1965. Passively-acquired immunity in experimental cryptococcosis. Sabouraudia 4: 80–84.
Louria, D. B., Kaminski, T. & Finkel, G., 1963. Further studies on immunity in experimental cryptococcosis. J. Exp. Med. 117: 509–520.
McGaw, T. G. & Kozel, T. R., 1979. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide. Infect. Immun. 25: 262–267.
Macher, A. M., Bennett, J. E., Gadek, J. E. & Frank, M. M., 1978. Complement depletion in cryptococcal sepsis. J. Immunol. 120: 1686–1690.
Marcus, S. & Rambo, F.R., 1955. Comparative aspects of the immunization of mice against systemic mycosis. Proc. Soc. Am. Bacteriol. 8: 92–95.
Mitchell, T. G. & Friedman, L., 1972. In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans. Infect. Immun. 5: 491–498.
Muchmore, H. G., Felton, F. G., Salvin, S. B. & Rhoades, E. R., 1969. Delayed hypersensitivity to cryptococcin in man. Sabouraudia 6: 285–288.
Muchmore, H. G., Scott, E. N., Felton, F. G. & Fromtling, R. A., 1981. Cryptococcal capsular polysaccharide clearance in nonimmune mice. Mycopathologia (in press).
Murphy, J. W. & Cozad, G. C., 1972. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect. Immun. 5: 896–901.
Murphy, J. W., Gregory, J. A. & Larsh, H. W., 1974. Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect. Immun. 9: 404–409.
Murphy, J. W. & Pahlavan, N., 1979. Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis. Infect. Immun. 25: 284–292.
Neill, J. M., Abrahams, I. & Kapros, C. E., 1950. A comparison of the immunogenicity of weakly encapsulated and of strongly encapsulated strains of Cryptococcus neoformans (Torula histolytica). J. Bacteriol. 59: 263–275.
Neilson, J. B., Fromtling, R. A. & Bulmer, G. S., 1981. Pseudohyphal forms of Cryptococcus neoformans: decreased survival in vivo. Mycopathologia 73: 57–59.
Neilson, J. B., Ivey, M. H. & Bulmer, G. S., 1978. Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga. Infect. Immun. 20: 262–266.
Papadimitrious, J. M., Robertson, T. A., Kletter, Y., Aronson, M. & Walters, M. N-I., 1978. An ultrastructural examination of the interaction between macrophages and Cryptococcus neoformans. J. Pathol 124: 103–109.
Powell, K. E., Dahl, B. A., Weeks, R. J. & Tosh, F. E., 1972. Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition. J. Infect. Dis. 125: 412–415.
Rappaport, B. Z. & Kaplan, B., 1926. Generalized Torula mycosis. Arch. Pathol. 1: 720–741.
Regelson, W., Morahan, P., Kaplan, A. M., Baird, L. G. & Munson, J. A., 1974. Synthetic polyanions: molecular weight, macrophage activation and immunologic response, p. 97–110. In: W. H. Wagner and H. Hahn (ed.) Activation of macrophages. Proc. 2nd Workshop Conf. Hoechst. Excerpta Medica, New York.
Regelson, W., Munson, A. & Wooles, W., 1970. The biologic activity of synthetic polymers: interferon inducers and reticuloendothelial response: polyanionic phylaxis against microorganisms and alterations of drug metabolism. Symp. Series Immunobiol. Standard. 14: 227–236.
Reiss, F. & Alture-Werber, E., 1976. Immunization of mice with a mutant of Cryptococcus neoformans. Dermatologia 152: 16–22.
Reiss, F., Szilagyi, G. & Mayer, E., 1975. Immunological studies of the anticryptococcal factor of normal human serum. Mycopathologia 55: 175–178.
Rhodes, J. C., Wicker, L. S. & Urba, W. J., 1980. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect. Immun. 29: 494–499.
Salvin, S. B. & Smith, R. F., 1961. An antigen for detection of hypersensitivity to Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 108: 498–501.
Schimpff, S. C. & Bennett, J. E., 1975. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. J. Allergy Clin. Immunol. 55: 430–441.
Schneerson-Porat, S., Shahar, A. & Aronson, M., 1965. Formation of histiocyte rings in response to Cryptococcus neoformans infection. J. Reticuloendoth. Soc. 2: 249–255.
Sethi, K. K. & Pelster, B., 1974. Destruction of Cryptococcus neoformans growth by non-specifically activated murine macrophages, p. 269–279. In: W. H. Wagner and H. Hahn (ed.) Activation of macrophages. Proc. 2nd Workshop Conf. Hoechst. Excerpta Medica, New York.
Shapiro, L. L. & Neil, J. B., 1925. Torula meningitis. Arch. Neurol. Psychiat. 13: 174–190.
Staib, F. & Mishra, S. K.., 1975. Contribution to the strainspecific virulence of Cryptococcus neoformans. Animal experiments with two C. neoformans strains isolated from bird manure. Zbl. Bakteriol. Hyg. I. Abt. Orig. A230: 81–85.
Tacker, J. R., Farhi, F. & Bulmer, G. S., 1972. Intracellular fate of Cryptococcus neoformans. Infect. Immun. 6: 162–167.
Vogel, R. A., Sellers, Jr. T. F. & Woodward, P., 1961. Fluorescent antibody techniques applied to the study of human cryptococcosis. J. Am. Med. Assoc. 178: 921–923.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fromtling, R.A., Shadomy, H.J. Immunity in cryptococcosis: An overview. Mycopathologia 77, 183–190 (1982). https://doi.org/10.1007/BF00518804
Issue Date:
DOI: https://doi.org/10.1007/BF00518804